Literature DB >> 31036096

Are neuropsychiatric symptoms modifiable risk factors for cognitive decline in Alzheimer's disease and vascular dementia?

George Savulich1, John T O'Brien2, Barbara J Sahakian3.   

Abstract

Alzheimer's disease and vascular dementia are associated with overlapping symptoms of anxiety and depression. More accurate discrimination between emerging neuropsychiatric and cognitive symptoms would better assist illness detection. The potential for protection against cognitive decline and dementia following early identification and intervention of neuropsychiatric symptoms warrants investigation.

Entities:  

Keywords:  Dementia; anxiety; depression; neuropsychiatric symptoms

Year:  2020        PMID： 31036096     DOI： 10.1192/bjp.2019.98

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN： 0007-1250            Impact factor:   9.319


  5 in total

1.  Morphometric similarity deviations in stimulant use disorder point towards abnormal brain ageing.

Authors:  Peter Zhukovsky; George Savulich; Sarah Morgan; Jeffrey W Dalley; Guy B Williams; Karen D Ersche
Journal:  Brain Commun       Date:  2022-03-28

2.  Neuropsychiatric Symptoms by Cognitive Status for Mexican-Americans Aged 85 and Older.

Authors:  Lan H Vu; Kyriakos S Markides; Brian Downer
Journal:  Gerontol Geriatr Med       Date:  2021-03-20

3.  Genetic risk for Alzheimer's disease, cognition, and mild behavioral impairment in healthy older adults.

Authors:  Byron Creese; Ryan Arathimos; Helen Brooker; Dag Aarsland; Anne Corbett; Cathryn Lewis; Clive Ballard; Zahinoor Ismail
Journal:  Alzheimers Dement (Amst)       Date:  2021-03-17

4.  The revised Addenbrooke's Cognitive Examination can facilitate differentiation of dementia with Lewy bodies from Alzheimer's disease.

Authors:  Maria Angeles Prats-Sedano; George Savulich; Ajenthan Surendranathan; Paul C Donaghy; Alan J Thomas; James B Rowe; Li Su; John T O'Brien
Journal:  Int J Geriatr Psychiatry       Date:  2020-12-14       Impact factor: 3.850

5.  Evaluating cognitive profiles of patients undergoing clinical amyloid-PET imaging.

Authors:  Flavia Loreto; Stephen Gunning; Mara Golemme; Hilary Watt; Neva Patel; Zarni Win; Christopher Carswell; Richard J Perry; Paresh A Malhotra
Journal:  Brain Commun       Date:  2021-03-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.